Breast Cancer Newswire (Page 10)

Comprehensive Real-Time News Feed for Breast Cancer. (Page 10)

Results 181 - 200 of 185,049 in Breast Cancer

  1. Produce industry supports breast cancer awarenessRead the original story w/Photo

    Wednesday | Packer

    Members of the produce industry are working to raise awareness of women's health in advance of Breast Cancer Awareness Month in October.

    Comment?

  2. Hormones after breast cancer: Not fuel for the fire after all?Read the original story

    Wednesday | PhysOrg Weblog

    A new study supports a growing body of research suggesting a safe and effective role for natural steroid hormones in treating postmenopausal breast cancer, with fewer detrimental side effects and improved health profile than with standard anti-hormone therapies.

    Comment?

  3. this story a-oRead the original story w/Photo

    Wednesday | GwdToday.com

    Lunden recently appeared on Good Morning America to announce that she has been diagnosed with an aggressive form of breast cancer: "I heard the words that every woman fears and never wants to hear, 'You have breast cancer,' Lunden, 63, told GMA anchor Robin Roberts, also a breast cancer survivor.

    Comment?

  4. Gene Study Gives New Insight Into Puberty in GirlsRead the original story w/Photo

    Wednesday | HON

    ... hope these findings will shed light on the biology of a number of diseases ranging from type 2 diabetes to breast cancer. "These findings will provide additional insights into how puberty timing is linked to the risk of disease in later life," said ...

    Comment?

  5. Stocks turn mostly higher as earnings roll inRead the original story w/Photo

    Wednesday | Washington Examiner

    ... a drug development company, soared after the company disclosed positive trial results for an experimental breast cancer drug. Puma rose $171.20, or 289 percent, to $230.05. Biogen Idec rose $32.93, or 11 percent, to $336.40 after the company's ...

    Comment?

  6. Why Puma Biotechnology (PBYI) Stock Is SpikingToday?Read the original story w/Photo

    Wednesday | TheStreet.com

    ... on Wednesday after the company reported positive top-line results from the Phase 3 trial of its neratinib breast cancer treatment. Analysts at Citigroup are speculating that the company is now a takeover target after Puma reported that patients who ...

    Comment?

  7. Stocks on the Move: Puma Biotechnology Inc, Intuitive Surgical, Inc., and Biogen Idec IncRead the original story

    Wednesday | SchaeffersResearch.com

    upbeat late-stage trial results for its experimental breast cancer drug. Earlier the stock tagged a new record peak of $236.91 -- nearly 65% above its previous all-time high of $143.65, tagged on Jan. 22. From a contrarian perspective, additional ...

    Comment?

  8. S&P 500 Makes New All-Time High: Here's What You Need To Know (Dia,...Read the original story w/Photo

    Wednesday | Silicon Alley Insider

    ... shares gained nearly 300% after the company last night reported positive results from a clinical trial of its breast cancer treatment. Puma's management said it plans to filed for marketing approval for the treatment in the first half of next year. ...

    Comment?

  9. ASU researchers discover new ways to diagnose cancerRead the original story w/Photo

    Wednesday | State Press

    ... can you do that?'" Johnston said there is indication from mouse models that diseases like Alzheimer's and breast cancer can be identified well in advance. "We reached out to the FDA expecting a negative reply, but they were pretty OK with it," ...

    Comment?

  10. Breast Cancer Drug Neratanib Meets Trial GoalRead the original story

    Wednesday | P&T Community

    Positive results have been reported from a phase III clinical study of the investigational drug neratinib , a pan-ErbB tyrosine kinase inhibitor, for the extended adjuvant treatment of breast cancer.

    Comment?

  11. Genesee County 4-H club recognized on state level in the fight against breast cancerRead the original story

    Wednesday | MLive.com

    Shelly Mochty , who was diagnosed with breast cancer in 2013, poses with her daughter Allie along with the rest of the Genesee County 4-H Explorers group recognized with the Michigan 4-H State Award for their work in hosting a Trick or Treat Trail Ride, raising money for Lope for Hope.

    Comment?

  12. Puma Biotechnology: Another Jackpot For InvestorsRead the original story w/Photo

    Wednesday | Forbes.com

    ... the value of the company close to $7 billion. The catalyst? Positive results from a Phase III trial of its breast cancer treatment investigational drug. Tests showed a 33% improvement in disease-free survival, when compared with a placebo. Puma ...

    Comment?

  13. Yellen mocked by tiny biotechs and InternetsRead the original story w/Photo

    Wednesday | USA Today

    ... warning. Shares are up $159.30, or 287%, to $228.33 today the day after the biotech told investors its breast cancer treatment, Neratinib, showed positive results. No stock even comes close to Puma, but Net Element is not shabby with its 69% gain ...

    Comment?

  14. Tips to make the most out of a 15-minute doctor visitRead the original story w/Photo

    Wednesday | WTOP-FM Washington

    ... minute of an office visit count. Leana Wen knows that only too well. She watched her mother battle metastatic breast cancer after being misdiagnosed for nearly a year when Wen was a medical student. "I saw for myself how much of a disconnect there ...

    Comment?

  15. Oncothyreon enjoys Puma's successRead the original story

    Wednesday | Seeking Alpha

    ... itive results from a Phase 3 clinical trial evaluating its HER2 inhibitor PB272 (neratinib) as a treatment for breast cancer.

    Comment?

  16. S&P 500 Aims At New High; Biotechs Gap Up In Fast TradeRead the original story

    Wednesday | Investor's Business Daily

    ... 287% in mammoth volume. The company on Tuesday announced good results from a phase-three clinical trial of a breast cancer drug. Puma recorded losses in the past three years, and the Street expects that to continue in 2014-15. (NASDAQ: AAPL ) thrust ...

    Comment?

  17. Cancer Institution at St. Joseph Medical Center- Part1Read the original story w/Photo

    Wednesday | Examiner.com

    ... decor suitable for the Royal Family. Dr. Schultz spearheads the treatment program for patients diagnosed with breast cancer . Breast Navigator, Susan F. Feild is definitely in the right field. She gets patients to warm up to her as she ...

    Comment?

  18. Why Oncotheryeon, Inc., OncoMed Pharmaceuticals, Inc., and Array BioPharma Inc. Stocks Jumped TodayRead the original story

    Wednesday | The Motley Fool

    ... as 10% and 16.4%, respectively, following a positive trial result from Puma Biotechnology 's HER2-positive breast cancer therapy neratinib. So What: Neratinib's astronomical success in a phase 3 trial for increasing disease-free survival in early ...

    Comment?

  19. Puma Shares Soar When Wall Street Misplays Expectation GameRead the original story w/Photo

    Wednesday | TheStreet.com

    ... Puma's experimental drug neratinib delayed the return of cancer in a large trial of women with early-stage breast cancer . Puma is why so many investors love to speculate on biotech stocks. A contrarian trade against a heavily expected outcome can ...

    Comment?

  20. Why Puma Biotechnology Inc Stock More Than Tripled TodayRead the original story

    Wednesday | The Motley Fool

    ... ) , a clinical-stage biotech, crushed the market with a gain of more than 280% Wednesday after the company's breast cancer drug neratinib met its primary goals in a phase 3 clinical trial. So What: Puma's neratinib trounced a placebo in the study, ...

    Comment?